CCERW: A new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people

Chinese Critical Care Medicine

Volumn 23, Issue 1, 2011, Pages 10-17

  Li, Jian Sheng ^a   Hou, Zheng Kun ^b   Li, Su Yun ^b   Yu, Xue Qing ^b   Sun, Zi Kai ^b   Zhang, Wei ^b   Jia, Xin Hua ^b   Zheng, Si Ping ^b   Wang, Ming Hang ^b   Wang, Hai Feng ^b  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b NONE

Author keywords

Community acquired pneumonia; Elderly; Middle aged; Model; Prognosis; Prognostic; Risk factor; Rule

Indexed keywords

CREATININE; NITROGEN; UREA;

ADULT; AGED HOSPITAL PATIENT; ARTICLE; BREATHING RATE; CCERW TOOL; CHINA; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; ELECTROLYTE DISTURBANCE; EXTERNAL VALIDITY; HEALTH STATUS; HUMAN; INTERNAL VALIDITY; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PNEUMONIA SEVERITY INDEX; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPIRATORY FAILURE; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; UNIVERSITY HOSPITAL; UREA NITROGEN BLOOD LEVEL;

AGED; CHINA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 79952239548     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2011.01.004     Document Type: Article

References (42)

1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community- acquired pneumonia in adults. CID, 2007,44:S27-72.
2. British Thoracic Society Standards of Care Committee. BTS guidelines for the mangement of community acquired pneumonia in adults. Thorax, 2001,56 Suppl 4: IV 1-64.
3. Kothe H, Bauer T, Marre R, et al. Outcome of community- acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J, 2008,32:139-146.
4. García-Vázquez E, Soto S, Gómez J, et al. Simple criteria to assess mortality in patients with community-acquired pneumonia. Med Clin (Barc), 2008,131:201-204. (Pubitemid 352031456)
5. Buising KL, Thursky KA, Black JF, et al. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas, 2007, 19:418-426. (Pubitemid 47547572)
6. España PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med, 2006,174: 1249-1256. (Pubitemid 44924826)
7. Dremsizov T, Clermont G, Kellum JA, et al. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest, 2006,129:968-978.
8. British Thoracic Society, Myint PK, Kamath AV, et al. Severity assessment criteria recommended by the British Thoracic Society(BTS) for community-acquired pneumonia (CAP) and older patients, should SOAR ( systolic blood pressure, oxygenation, age and respiratory rate)criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing, 2006,35:286-291.
9. Saldías F, Farías G, Villarroel L, et al. Development of an instrument to assess the severity of community acquired pneumonia among hospitalized patients. Rev Med Chil, 2004, 132:1037-1046.
10. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital, an international derivation and validation study. Thorax, 2003, 58:377-382. (Pubitemid 36560938)
11. Kamath A, Pasteur MC, Slade MG, et al. Recognising severe pneumonia with simple clinical and biochemical measurements. Clin Med, 2003,3:54-56. (Pubitemid 36232190)
12. García-Ordóñez MA, García-Jiménez JM, Páez F, et al. Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia. Eur J Clin Microbiol Infect Dis, 2001,20:14-19. (Pubitemid 32200356)
13. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax, 2000,55:219-223. (Pubitemid 30245972)
14. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med, 1997,336:243-250. (Pubitemid 27044625)
15. Neill AM, Martin IR, Weir R, et al. Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax, 1996,51:1010-1016. (Pubitemid 26360177)
16. Conte HA, Chen YT, Mehal W, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med, 1999,106:20-28. (Pubitemid 29077138)
17. Leroy O, Georges H, Beuscart C, et al. Severe community- acquired pneumonia in ICUs: prospective validation of a prognostic score. Intensive Care Med, 1996,22:1307-1314. (Pubitemid 27007763)
18. Renaud B, Labarère J, Coma E, et al. Risk stratification of early admission to the intensive care unit of patients with no major criteria of severe community-acquired pneumonia: development of an international prediction rule. Crit Care, 2009,13:R54.
19. España PP, Capelastegui A, Quintana JM, et al. A prediction rule to identify allocation of inpatient care in community- acquired pneumonia. Eur Respir J, 2003,21:695-701. (Pubitemid 36432527)
20. de Castro FR, Torres A. Optimizing treatment outcomes in severe community-acquired pneumonia. Am J Respir Med, 2003,2:39-54. (Pubitemid 37062716)
21. Leroy O, Devos P, Guery B, et al. Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest, 1999,116:157-165. (Pubitemid 29340277)
22. Raz R, Dyachenko P, Levy Y, et al. A predictive model for the management of community-acquired pneumonia. Infection, 2003,31:3-8. (Pubitemid 36183075)
23. Ruiz-González A, Falguera M, Vives M, et al. Community- acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology. Respir Med, 2000,94:505-510. (Pubitemid 30353010)
24. Chan SS, Yuen EH, Kew J, et al. Community-acquired pneumonia - implementation of a prediction rule to guide selection of patients for outpatient treatment. Eur J Emerg Med, 2001, 8:279-286.
25. Bont J, Hak E, Hoes AW, et al. A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J, 2007,29:969-975. (Pubitemid 46711903)
26. Menéndez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax, 2008,63:447-452. (Pubitemid 351692355)
27. Menéndez R, Torres A, Zalacaín R, et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax, 2004,59:960-965. (Pubitemid 39490781)
28. Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med, 2009,30:154-160.
29. Rosón B, Carratalà J, Fernández-Sabé N, et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med, 2004, 164:502-508. (Pubitemid 38314445)
30. Aliberti S, Amir A, Peyrani P, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest, 2008, 134:955-962.
31. Hershberger E, Lajin M, Chirilla R, et al. Treatment failure with out-patient therapy of community-acquired pneumonia. Abstr Intersci Conf Antimicrob Agents Chemother Intersci Conf Antimicrob Agents Chemother, 2001,41:L1847.
32. Hoogewerf M, Oosterheert JJ, Hak E, et al. Prognostic factors for early clinical failure in patients with severe community- acquired pneumonia. Clin Microbiol Infect, 2006, 12: 1097-1104. (Pubitemid 44462844)
33. Genné D, Sommer R, Kaiser L, et al. Analysis of factors that contribute to treatment failure in patients with community- acquired pneumonia. Eur J Clin Microbiol Infect Dis, 2006, 25:159-166.
34. Loh LC, Khoo SK, Quah SY, et al. Adult community-acquired pneumonia in Malaysia, prediction of mortality from severity assessment on admission. Respirology, 2004,9:379-386.
35. U. S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: evaluating clinical studies of antimicrobials in the division of anti-infective drug products. Washington DC:HHS,FDA,1997:1-99.